Lexeo Therapeutics Stock Forward View - Accumulation Distribution
| LXEO Stock | 6.90 0.01 0.15% |
Lexeo Stock outlook is based on your current time horizon. Although Lexeo Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Lexeo Therapeutics' systematic risk associated with finding meaningful patterns of Lexeo Therapeutics fundamentals over time.
As of today, the RSI of Lexeo Therapeutics' share price is approaching 34. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Lexeo Therapeutics, making its price go up or down. Momentum 34
Sell Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.42) | EPS Estimate Current Year (1.92) | EPS Estimate Next Year (1.47) | Wall Street Target Price 19.6364 | EPS Estimate Current Quarter (0.44) |
Using Lexeo Therapeutics hype-based prediction, you can estimate the value of Lexeo Therapeutics Common from the perspective of Lexeo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Lexeo Therapeutics using Lexeo Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Lexeo using crowd psychology based on the activity and movement of Lexeo Therapeutics' stock price.
Lexeo Therapeutics Implied Volatility | 2.74 |
Lexeo Therapeutics' implied volatility exposes the market's sentiment of Lexeo Therapeutics Common stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Lexeo Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Lexeo Therapeutics stock will not fluctuate a lot when Lexeo Therapeutics' options are near their expiration.
Lexeo Therapeutics after-hype prediction price | USD 6.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Lexeo Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Lexeo contract
Based on the Rule 16, the options market is currently suggesting that Lexeo Therapeutics Common will have an average daily up or down price movement of about 0.17% per day over the life of the 2026-05-15 option contract. With Lexeo Therapeutics trading at USD 6.9, that is roughly USD 0.0118 . If you think that the market is fully incorporating Lexeo Therapeutics' daily price movement you should consider acquiring Lexeo Therapeutics Common options at the current volatility level of 2.74%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Lexeo Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Lexeo Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Lexeo Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Lexeo Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Lexeo Therapeutics' open interest, investors have to compare it to Lexeo Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Lexeo Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Lexeo. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Lexeo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Lexeo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lexeo using various technical indicators. When you analyze Lexeo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 21611.9 | 17963.95 |
| Check Lexeo Therapeutics Volatility | Backtest Lexeo Therapeutics | Information Ratio |
Lexeo Therapeutics Trading Date Momentum
| On February 26 2026 Lexeo Therapeutics Common was traded for 6.90 at the closing time. The top price for the day was 6.92 and the lowest listed price was 6.63 . The trading volume for the day was 428.7 K. The trading history from February 26, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.14% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Lexeo Therapeutics to competition |
Other Forecasting Options for Lexeo Therapeutics
For every potential investor in Lexeo, whether a beginner or expert, Lexeo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lexeo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lexeo. Basic forecasting techniques help filter out the noise by identifying Lexeo Therapeutics' price trends.Lexeo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Lexeo Therapeutics stock to make a market-neutral strategy. Peer analysis of Lexeo Therapeutics could also be used in its relative valuation, which is a method of valuing Lexeo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Lexeo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Lexeo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lexeo Therapeutics shares will generate the highest return on investment. By undertsting and applying Lexeo Therapeutics stock market strength indicators, traders can identify Lexeo Therapeutics Common entry and exit signals to maximize returns.
Lexeo Therapeutics Risk Indicators
The analysis of Lexeo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lexeo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lexeo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.23 | |||
| Standard Deviation | 4.86 | |||
| Variance | 23.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Lexeo Therapeutics
The number of cover stories for Lexeo Therapeutics depends on current market conditions and Lexeo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lexeo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lexeo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Lexeo Therapeutics Short Properties
Lexeo Therapeutics' future price predictability will typically decrease when Lexeo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lexeo Therapeutics Common often depends not only on the future outlook of the potential Lexeo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lexeo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.8 M | |
| Cash And Short Term Investments | 121.5 M |
Check out Historical Fundamental Analysis of Lexeo Therapeutics to cross-verify your projections. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Will Biotechnology sector continue expanding? Could Lexeo diversify its offerings? Factors like these will boost the valuation of Lexeo Therapeutics. Expected growth trajectory for Lexeo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lexeo Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Lexeo Therapeutics Common using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Lexeo Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Lexeo Therapeutics' market price to deviate significantly from intrinsic value.
Understanding that Lexeo Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lexeo Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Lexeo Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.